In silico screening of chalcone derivatives as promising EGFR-TK inhibitors for the clinical treatment of cancer.
Shalini MathpalTushar JoshiPriyanka SharmaPriyanka MaitiMahesha NandVeena PandeSubhash ChandraPublished in: 3 Biotech (2023)
The online version contains supplementary material available at 10.1007/s13205-023-03858-8.